For non-small-cell lung cancer: In combination with platinum based therapy for the treatment of inoperable or stage IIIb or IV non-small cell lung cancer.
For breast cancer: In mono-therapy for the treatment of metastatic or relapsed breast cancer after or refractory to an anthracycline containing regimen. In combination with capecitabine for the treatment of metastatic or relapsed breast cancer after or refractory to an anthracycline containing regimen.
Other Services
Country
Account